SPECT lung scans show low clot risk at three months, suggesting a potential alternative to CT in pulmonary embolism diagnosis ...
Stockhead on MSN
March ASX Health Wrap: Sector falls ~7pc on Middle East war, but standout stocks defy drop
The ASX healthcare sector fell ~7% in March as war in the Middle East rattled investors, taking a toll on ... Read More The ...
Researchers at Flinders University have tested a vision-enabled AI clinical scribe combining Google Gemini and Ray-Ban Meta ...
DMedical announced today that it received CE mark approval for its CT:VQ SaaS imaging platform and raised approximately $60 million.
Hyperventilation is common in EMS. Pulmonary embolism (PE) is not. That imbalance creates risk. Experience teaches us to recognize what we see often. But PE is one of those diagnoses that punishes ...
CT:VQ™ is 4DMedical's proprietary ventilation-perfusion imaging solution that generates functional lung information from non-contrast CT scans. Built on the Company's patented XV Technology®, CT:VQ™ ...
After one of the most spectacular runs in recent ASX history, 4DMedical shares (ASX: 4DX) have entered a sharp correction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results